You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-Allergic Agents

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anti-HLA Immunization And Immunosuppressive Therapy Management

Active, not recruiting
  • Kidney Transplantation
  • +3 more
  • management of immunosuppressive therapy
  • Nancy, Lorraine, France
    Central HNF
Mar 24, 2022

Tumors, Carcinoma, Squamous, Antineoplastic Agents Trial (Nivolumab Injection [Opdivo])

Not yet recruiting
  • Neoplasms
  • +2 more
  • Nivolumab Injection [Opdivo]
  • (no location specified)
Jul 19, 2023

Cancer, Solid Tumors Trial in United States (Vevorisertib, Fulvestrant, Paclitaxel)

Terminated
Has Results
  • Cancer
  • Solid Tumors
  • Las Vegas, Nevada
  • +5 more
Jun 14, 2022

Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCC

Recruiting
  • Hepatocellular Carcinoma
  • Anti-angiogenic agents plus anti-PD-1/PD-L1 antibodies
  • Shanghai, Shanghai, China
    Zhongshan Hospital, Fudan University
Jul 23, 2021

The Lymphoid Tissue Pharmacology of Antiretroviral Drugs

Not yet recruiting
  • HIV Infection
  • Anti-HIV Agents
  • (no location specified)
Nov 4, 2022

Tissue Adhesion, Gynecologic Surgery Trial in Taipei (PROTAHERE Absorbable Adhesion Barrier, Hyalobarrier Gel, No treatment)

Active, not recruiting
  • Tissue Adhesion
  • Gynecologic Surgery
  • PROTAHERE Absorbable Adhesion Barrier
  • +4 more
  • Taipei, Taiwan
    Taipei Veterans General Hospital
Jan 5, 2022

Ocular Adverse Events in Neovascular Age-related Macular

Completed
  • Age-related Macular Degeneration (AMD)
  • Aflibercept
  • +2 more
  • East Hanover, New Jersey
    Novartis Investigative Site
Dec 15, 2021

Alcohol Drinking, Alcohol-Related Disorders, Disease Trial in Catonsville (Minocycline, Sugar pill)

Recruiting
  • Alcohol Drinking
  • +15 more
  • Catonsville, Maryland
    Maryland Psychiatric Research Center (MPRC) Treatment Research P
Nov 29, 2022

Variable Effects of Anti-diabetics on Stress Hyperglycemia Ratio

Completed
  • Type 2 Diabetes
  • Sitagliptin/metformin ( 50/500mg) Oral Tablet
  • Empagliflozin/metformin(10/500mg) Oral Tablet
  • Baqubah, Diyala, Iraq
    College of Medicine, University of Diyala
Apr 7, 2023

Esophageal Squamous Cell Carcinoma Trial (Paclitaxel, Irinotecan, Pembrolizumab)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Chuo-ku, Tokyo, Japan
    National Cancer Center Hospital ( Site 3700)
Jan 31, 2023

Advanced Solid Malignancies Trial in Worldwide (AZD9574, Temozolomide)

Recruiting
  • Advanced Solid Malignancies
  • La Jolla, California
  • +30 more
Dec 20, 2022

Tuberculous Lymphadenitis Trial in Taipei (Prednisolone, standard anti-tuberculosis agents)

Recruiting
  • Tuberculous Lymphadenitis
  • Taipei, Taiwan
    National Taiwan University Hospital
May 17, 2023

AREG, EREG and EGFR: Response to Anti-EGFR Agents in Colorectal

Active, not recruiting
  • Colorectal Cancer Stage IV
  • Immunohistochemistry
  • Huddersfield, West Yorkshire, United Kingdom
  • +6 more
Feb 22, 2022

Juvenile Idiopathic Arthritis Associated Uveitis Trial in Cairo (biologic DMARDs)

Active, not recruiting
  • Juvenile Idiopathic Arthritis Associated Uveitis
  • biologic DMARDs
  • Cairo, Egypt
    Faculty of medicine, Cairo university
Sep 12, 2022

ABPA, Severe Asthma, Allergic Bronchopulmonary Aspergillosis Trial in Dallas (Fasenra, 30 Mg/mL Subcutaneous Solution)

Withdrawn
  • ABPA
  • +2 more
  • Fasenra, 30 Mg/mL Subcutaneous Solution
  • Dallas, Texas
    Baylor University Medical Center
Jan 17, 2022

Tumors Trial in San Jose del Cabo, Torreon (Anti-Bacterial Agents, Anti-Fungal Agents, Anti-Protozoal Agents)

Recruiting
  • Neoplasms
  • Anti-Bacterial Agents
  • +2 more
  • San Jose del Cabo, Baja California Sur, Mexico
  • +1 more
Mar 26, 2022

Asthma, Allergic Trial in Guangzhou, Wenzhou (CMAB007, Symbicort, Seretide)

Completed
  • Asthma, Allergic
  • Guangzhou, Guangdong, China
  • +1 more
Oct 8, 2021

Allergic Rhinitis Trial in London (behavioral, device, procedure)

Completed
  • Allergic Rhinitis
  • Probiotic or placebo yogurt consumed daily
  • +3 more
  • London, Ontario, Canada
    Lawson Health Research Institute - Canadian Research and Develop
Aug 25, 2021

Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial (biological, procedure, drug)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Atezolizumab
  • +5 more
  • (no location specified)
Feb 4, 2023

Ocular Adverse Events in Neovascular Agerelated Macular

Completed
  • Age-related Macular Degeneration (AMD)
  • Aflibercept
  • +2 more
  • East Hanover, New Jersey
    Novartis Investigative Site
Dec 15, 2021

Adrenal Gland Pheochromocytoma, Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial run by the National Cancer

Recruiting
  • Adrenal Gland Pheochromocytoma
  • +3 more
  • Computed Tomography
  • +2 more
  • Bethesda, Maryland
  • +1 more
Jan 3, 2023

Breast Cancer, Solid Tumor, Adult Trial in United States (APG-2575, Palbociclib)

Recruiting
  • Breast Cancer
  • Solid Tumor, Adult
  • Atlanta, Georgia
  • +3 more
Aug 12, 2022

Intravitreal Injection Site and Perceived Pain

Recruiting
  • Pain
  • Intravitreal injection site
  • Galveston, Texas
    University of Texas Medical Branch
Jan 19, 2023

Advanced Solid Tumours, Carcinoma Non-small Cell Lung, Head and Neck Tumors Trial in Worldwide (AZD9592, Osimertinib)

Recruiting
  • Advanced Solid Tumours
  • +2 more
  • Duarte, California
  • +13 more
Jan 5, 2023

Biliary Atresia, Cholangitis, Anti-Bacterial Agents Trial (Basic treatment: sulperazone + ursodeoxycholic acid + compound

Not yet recruiting
  • Biliary Atresia
  • +2 more
  • Basic treatment: sulperazone + ursodeoxycholic acid + compound glycyrrhizin + methylprednisolone + vitamin AD , D , E , K + imipenem or meropenem
  • Prophylactic oral antibiotics: compound sulfamethoxazole tablet (SMZ/TMP) + cefaclor
  • (no location specified)
Jun 28, 2023